After clicking on a story, use the back arrow in your browser to return to your search results. Use phrases "in quotes" or the tools below to better filter your results.
Patents expiring between 2025-2030 will put more than $200 billion of Big Pharma’s revenues at risk, thus positioning them to fill their pipelines through acquisitions.
Spearmint has hired Chris Wright as senior vice president of project technology, Jeff Jackson as senior vice president of project execution, and Nicolas Cottely as vice president of project finance.